While most current antipsychotics are effective at reducing the positive symptoms of schizophrenia, ...
Substance use—known to be common in people with psychosis—is associated with poorer outcomes, includ...
Although a phase-2 clinical trial reported recently in JAMA Psychiatry suggested that an NMDA recept...
